Señales en vivo de KAEF.JK | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 may 2024 @ 22:45):

PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia...

Stats
Volumen de hoy	107 800
Volumen promedio	4.94M
Capitalización de mercado	4 091.40B
EPS	IDR0 ( 2024-04-29 )
Próxima fecha de ganancias	( IDR0 ) 2024-07-24
Last Dividend	IDR0 ( N/A )
Next Dividend	IDR0 ( N/A )
P/E	-24.55
ATR14	IDR2.06 (0.28%)

Volumen Correlación

Largo: -0.12 (neutral)

Corto: 0.00 (neutral)

Signal:(54.393) Neutral

PT Kimia Farma (Persero) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PT Kimia Farma (Persero) Correlación - Moneda/Commodity

0.00
( neutral )

0.03
( neutral )

-0.46
( neutral )

-0.27
( neutral )

0.56
( weak )

0.17
( neutral )

PT Kimia Farma (Persero) Finanzas

Annual	2022
Ingresos:	IDR9 606.15B
Beneficio Bruto:	IDR3 592.84B (37.40 %)
EPS:	IDR-16.98

FY	2022
Ingresos:	IDR9 606.15B
Beneficio Bruto:	IDR3 592.84B (37.40 %)
EPS:	IDR-16.98

FY	2021
Ingresos:	IDR12 857.63B
Beneficio Bruto:	IDR4 396.29B (34.19 %)
EPS:	IDR54.42

FY	2020
Ingresos:	IDR10 006.17B
Beneficio Bruto:	IDR3 657.13B (36.55 %)
EPS:	IDR3.18

Financial Reports:

No articles found.

PT Kimia Farma (Persero)

PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It also manufactures and sells generic, ethical, license and narcotic medicines, and over the counter medicines, health equipment, raw materials, medicines, medical devices, and cosmetics. In addition, the company distributes its products in drug to pharmacies, hospital pharmacy installation, medical center, and drug stores. The company was founded in 1817 and is headquartered in Jakarta, Indonesia.